Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACAP38 and Sumatriptan in Patients With Rosacea
NCT03878784Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Nov 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sumatriptan in rosacea (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Incidence of headache and migraine at 24 hours and Effect of sumatriptan at 24 hours. Started Nov 2018; status: completed.
02
Drugs
sumatriptan
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03878784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878784.